Exousia Bio (LMMY) Enterprise Value (2024 - 2026)

Exousia Bio (LMMY) has 4 years of Enterprise Value data on file, last reported at -$1028.0 in Q1 2025.

• Quarterly Enterprise Value changed 0.0% year-over-year to -$1028.0 in Q1 2025, while the trailing twelve-month figure through Feb 2025 was -$1028.0 (changed 0.0% YoY) and the FY2024 annual result came in at -$1028.0, up 86.91% from the prior year.
• Enterprise Value was little changed at -$1028.0 in Q1 2025 per LMMY's latest filing, from -$1028.0 in the prior quarter.
• The five-year high for Enterprise Value was -$1028.0 in Q4 2023, with the low at -$10107.0 in Q2 2022.
• Average Enterprise Value over 4 years is -$2814.8, with a median of -$1028.0 recorded in 2023.
• The widest YoY moves for Enterprise Value: up 86.91% in 2024, down 0.0% in 2024.
• Exousia Bio's Enterprise Value stood at -$1351.0 in 2022, then grew by 23.91% to -$1028.0 in 2023, then changed by 0.0% to -$1028.0 in 2024, then changed by 0.0% to -$1028.0 in 2025.
• Business Quant data shows LMMY's Enterprise Value at -$1028.0 in Q1 2025, -$1028.0 in Q4 2024, and -$1028.0 in Q3 2024.